[1] MITSURU KAKIHANA Akinobu N Masahiro SUNO. Antihypertensive Effect of CV-4093-2HCI, a New Calcium Antagonist, in Three Rat Models of Hypertension[J]. Japanese journal of pharmacology, 1988, 48 2: Pages 223-228. DOI:
10.1254/jjp.48.223[2] KATE MCKEAGE Lesley J S. Manidipine: a review of its use in the management of hypertension.[J]. Drugs, 2004, 64 17: 1923-1940. DOI:
10.2165/00003495-200464170-00011[3] MOHAMMAD M. GHAHREMANPOUR. Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2[J]. ACS Medicinal Chemistry Letters, 2020, 11 12: 2526-2533. DOI:
10.1021/acsmedchemlett.0c00521[4] BEATRICE MERCORELLI . Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein[J]. Antiviral research, 2018, 150: Pages 130-136. DOI:
10.1016/j.antiviral.2017.12.014